Sumitomo Mitsui Trust Holdings Inc. grew its position in Agilent Technologies, Inc. (NYSE:A) by 9.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 998,225 shares of the medical research company’s stock after buying an additional 90,317 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc. owned 0.31% of Agilent Technologies worth $64,086,000 at the end of the most recent reporting period.
Other hedge funds have also recently modified their holdings of the company. Advisor Group Inc. lifted its stake in shares of Agilent Technologies by 0.3% during the 2nd quarter. Advisor Group Inc. now owns 3,959 shares of the medical research company’s stock worth $235,000 after purchasing an additional 10 shares during the last quarter. Bronfman E.L. Rothschild L.P. lifted its stake in shares of Agilent Technologies by 0.8% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 4,658 shares of the medical research company’s stock worth $276,000 after purchasing an additional 35 shares during the last quarter. Veritable L.P. lifted its stake in shares of Agilent Technologies by 0.4% during the 2nd quarter. Veritable L.P. now owns 10,896 shares of the medical research company’s stock worth $646,000 after purchasing an additional 40 shares during the last quarter. Balentine LLC lifted its stake in shares of Agilent Technologies by 2.9% during the 2nd quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock worth $106,000 after purchasing an additional 50 shares during the last quarter. Finally, Kingfisher Capital LLC lifted its stake in shares of Agilent Technologies by 0.3% during the 2nd quarter. Kingfisher Capital LLC now owns 22,643 shares of the medical research company’s stock worth $1,343,000 after purchasing an additional 58 shares during the last quarter.
COPYRIGHT VIOLATION NOTICE: This report was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://sportsperspectives.com/2017/11/19/sumitomo-mitsui-trust-holdings-inc-raises-holdings-in-agilent-technologies-inc-a.html.
Agilent Technologies, Inc. (NYSE:A) opened at $68.79 on Friday. The company has a quick ratio of 2.76, a current ratio of 3.22 and a debt-to-equity ratio of 0.39. The firm has a market capitalization of $22,138.55, a PE ratio of 30.04, a PEG ratio of 2.70 and a beta of 1.27. Agilent Technologies, Inc. has a 1-year low of $42.92 and a 1-year high of $69.09.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be issued a $0.149 dividend. The ex-dividend date of this dividend is Friday, December 29th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.87%. Agilent Technologies’s dividend payout ratio is currently 27.32%.
In other news, CEO Michael R. Mcmullen sold 16,492 shares of the stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $65.33, for a total value of $1,077,422.36. Following the transaction, the chief executive officer now directly owns 211,872 shares of the company’s stock, valued at $13,841,597.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Didier Hirsch sold 72,545 shares of the stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $62.38, for a total value of $4,525,357.10. The disclosure for this sale can be found here. Insiders sold 140,292 shares of company stock worth $8,917,544 over the last three months.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.